This work may also be useful for people with type-1 diabetes or other people with glucose-metabolism disorders who visit high altitude due to the lower insulin levels observed among participants upon arrival, higher insulin levels within a few days of arrival, which then decrease (Richards and Hillebrandt 2013). This evidence concerns the gene INS and glucose metabolism disease.